Medical Imaging Market by Product Type, Distribution Channel, End User 2024-2032
                     Global Medical Imaging 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
IMARC Group is  a g lobal  management  consul t ing f i rm that  he lps the wor ld ’s  most  ambi t ious 
changemakers  to create a las t ing impact .  Across the s ix  major  cont inents  and 100+ count r ies ,  we 
work a longside our  bus iness par tners  as one team wi th  a common ambi t ion to achieve unparal le led 
resul ts ,  gain a compet i t ive edge,  and t ransform indust r ies .  IMARC Group excels  in  unders tanding 
i ts  c l ients ’  bus iness pr ior i t ies  and del iver ing ta i lored solut ions that  dr ive meaningfu l  outcomes.  Our 
c l ient  base spans over  3,000 organizat ions in  the pr ivate,  publ ic ,  and soc ia l  sectors ,  ranging f rom 
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of  market  entry  and expansion serv ices.  Our of fer ings inc lude 
thorough market  assessment ,  feas ib i l i ty  s tudies,  company incorporat ion ass is tance,  fac tory  setup 
suppor t ,  regulatory  approvals and l icens ing navigat ion,  branding,  market ing and sales st rategies,  
compet i t ive landscape and benchmark ing analyses,  pr ic ing and cost  research,  and procurement  
research.  These serv ices are des igned to ass is t  companies in  evaluat ing market  oppor tuni t ies ,  
set t ing up new ent i t ies ,  navigat ing regulatory landscapes,  boost ing brand v is ib i l i ty ,  analyz ing 
compet i tors,  and opt imiz ing procurement  s t rategies.
Accord ing  t o  the  la tes t  repo r t  by  IMARC Group ,  t i t l ed  "Med ica l  Imag ing  Market :  
G loba l  I ndust ry  T rends ,  Share ,  S ize ,  Grow th ,  Opportun i ty  and  Forecast  2024-
2032, "  t he  g loba l  med i ca l  im ag ing  marke t  s i ze  reached  US$ 42 .3  B i l l i on  in  2023 .
Factors Af fect ing  the  Growth  of  the Medica l  Imaging Industry:
Report Technologica l  Advancements:The  rap id  pace  o f  t echno log ica l  advancement s  in  t he  med ica l  imag ing  sec to r  i s  
impe l l i ng  t he  marke t  g rowt h .  I nnovat ions ,  such  as  a r t i f i c ia l  i n te l l i gence  (A I ) ,  
Highlight and mach ine  learn ing  (ML) ,  and  advanced  imag ing  moda l i t i es  l i ke  3D and  4D im ag ing  
have revo lu t ion ized  d iagnos t i c  capab i l i t i es .  A I  and  ML  a lgo r i t hms enhance  image  
Description process ing  and in te rp re ta t ion ,  l ead ing  t o  more  accu ra te  d iagnoses  and pe rsona l i zed  t rea tment  p lans .  
Add i t i ona l l y ,  t he  deve lopmen t  o f  po r t ab le  and  handhe ld  imag ing  dev ices  i s  
inc reas ing  access ib i l i t y  t o  med ica l  imag ing  se rv ices ,  even  in  remote  and 
underse rved areas .  These  advancement s  no t  on ly  improve  t he  qua l i t y  o f  pa t ien t  
ca re  bu t  a l so  s t ream l i ne  work f low  e f f i c iency  i n  hea l t hca re  f ac i l i t i es ,  t he reby  
reduc ing  opera t iona l  cos ts .
Increasing Prevalence of Chronic Diseases:
The r is ing  inc idence  o f  chron ic  d iseases ,  such as  cancer ,  ca rd iovascu la r  
d iseases,  and neuro log ica l  d isorders ,  s ign i f i can t ly  dr i ves  the  demand fo r  
medica l  imag ing .  Ear ly  detec t ion  and con t inuous mon i to r ing o f  these 
cond i t ions  are  cruc ia l  fo r  e f fec t i ve  t rea tment  and management .  Med ica l  
Report imag ing  p lays  a  v i ta l  ro le  in  d iagnos ing these d iseases  a t  an  ear ly  s tage,  
enab l ing  t ime ly  in te rvent ion  and  improved pa t ien t  outcomes.  
Highlight and Moreover ,  mammography fo r  b reas t  cancer  detec t ion  and computed  
tomography (CT)  scans for  assess ing card iovascu lar  cond i t ions  have  
Description become s tandard  p rac t ices  in  prevent ive  hea l thcare .  The  growing  ag ing  popula t ion,  wh ich i s  more  suscep t ib le  to  chron ic  i l l nesses,  fu r ther  dr ives the 
need for  advanced imaging  technolog ies .
Rising Demand for  Ear ly Diagnosis and Preventive Care:
There  i s  an  increase  in  the emphas is  on ear ly  d iagnos is  and  p reven t ive  care  
in  modern hea l thcare ,  wh ich  ca ta lyzes the  demand fo r  med ica l  imag ing.  
Ear ly  de tec t ion  o f  d iseases  can lead  to  more successfu l  t rea tment  ou tcomes 
and  reduce the overa l l  burden on  hea l thcare  sys tems.
Preven t i ve  imag ing  sc reen ings ,  such  as  regu la r  u l t rasounds ,  a re  becoming  
more  common as  par t  o f  rou t ine  hea l th  check -ups .  Gove rnmen ts  and  
hea l thcare  o rgan iza t ions  a re  a l so  invest ing  in  pub l i c  hea l th  campa igns  and  
sc reen ing  p rograms  to  p romote  ear l y  d iagnos is .  Th is  p roac t ive  approach  no t  
on ly  enhances  pa t ien t  qua l i t y  o f  l i fe  bu t  a lso  con t r ibu tes  to  cos t  sav ings  in  
Report hea l thcare  by  mi t i ga t ing  the  need  fo r  more  ex tens ive  and  expens ive  t rea tmen ts  a t  l a te r  s tages .
Highlight and Request  for  a  PDF sample  o f  th is  repor t :  
h t tps : / /www. imarcgroup .com/med ica l - imag ing-marke t / reques tsamp le
Description
Report Description
Global Medical Imaging Market Trends:
Rising  awareness and educat ion about  the benef i ts  o f  ear ly  d iagnosis  and advanced imaging 
technolog ies are contr ibut ing to  the growth of  the market .  Publ ic  heal th  campaigns and educat iona l  
in i t ia t ives by heal thcare organizat ions and governments emphasize the impor tance of  regular  
screenings and ear ly detect ion of  d iseases.  Improved awareness leads to  h igher  pat ient  compl iance 
wi th  recommended imaging procedures,  increasing the demand for  imaging serv ices.  
Addi t iona l ly ,  educat ion and t ra in ing programs for  heal thcare profess ionals  ensure that  they are wel l -
equipped to  u t i l ize  advanced imaging technolog ies e f fect ive ly .  Th is not  on ly  enhances the qual i ty  o f  
pat ient  care but  a lso dr ives the adopt ion of  innovat ive imag ing so lu t ions in  c l in ica l  pract ice.
View Report  TOC, F igures and Tables :  ht tps: / /www.imarcgroup.com/medical- imaging-market
Breakup by Product:
• CT Scanners
• X-Ray Imaging Systems
• MRI Systems
• Ultrasound Imaging Systems
• Nuclear Imaging Systems
• Mammography Systems
Report 
Segmentation Breakup by Application:
• Obstetr ics  and Gynecology Health
• Orthopedics and Musculoske letal
• Neuro and Spine
• Cardiovascular  and Thorac ic
• General  Imaging
• Breast Health
• Others
Breakup by End User:
• Hospitals
• Diagnost ic Centers
• Academic Insti tutes and Research 
Organizat ions
Report Breakup by Region:
• North America
Segmentation
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Canon Medical Systems Corporat ion (Canon 
Inc.)
• Carestream Health
• Cubresa Inc.
• Esaote SpA
Competitive • FUJIFILM VisualSonics Inc.
• GE HealthCare (General  Electr ic Company)
Landscape 
• Hologic Inc.
with Key • Koning Corporation
Players • Koninkl i jke Phi l ips N.V.
• Mater ial ise NV
• Mindray Medical International Limited
• Samsung Medison Co.  Ltd.  (Samsung 
Electronics Co. Ltd.)
• Siemens Healthineers AG (Siemens AG).
What was the size of the global medical imaging market 
in 2023?
What is the expected growth rate of the global medical 
imaging market during 2024-2032?
What are the key factors driving the global medical 
imaging market?
Key 
What has been the impact of COVID-19 on the global 
Questions medical imaging market?
Answered in What is the breakup of the global medical imaging market based on the product?
the Report What is the breakup of the global medical imaging 
market based on the application?
What is the breakup of the global medical imaging 
market based on the end user?
What are the key regions in the global medical imaging 
market?
Who are the key players/companies in the global 
medical imaging market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  M e d i c a l  I m a g i n g  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t
    6 . 1     C T  S c a n n e r s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     X - R a y  I m a g i n g  S y s t e m s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     M R I  S y s t e m s
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     U l t r a s o u n d  I m a g i n g  S y s t e m s
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
    6 . 5     N u c l e a r  I m a g i n g  S y s t e m s
        6 . 5 . 1  M a r k e t  T r e n d s
        6 . 5 . 2  M a r k e t  F o r e c a s t
    6 . 6     M a m m o g r a p h y  S y s t e m s
        6 . 6 . 1  M a r k e t  T r e n d s
        6 . 6 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
Table of     7 . 1     O b s t e t r i c s  a n d  G y n e c o l o g y  H e a l t h        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     O r t h o p e d i c s  a n d  M u s c u l o s k e l e t a l
Contents         7 . 2 . 1  M a r k e t  T r e n d s        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     N e u r o  a n d  S p i n e
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     C a r d i o v a s c u l a r  a n d  T h o r a c i c
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
    7 . 5     G e n e r a l  I m a g i n g
        7 . 5 . 1  M a r k e t  T r e n d s
        7 . 5 . 2  M a r k e t  F o r e c a s t
    7 . 6     B r e a s t  H e a l t h
        7 . 6 . 1  M a r k e t  T r e n d s
        7 . 6 . 2  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /m ed i c a l - im a g i ng -m a rke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: